567-62-4 Usage
Uses
Used in Pharmaceutical Production:
Benzoic acid, 2-amino-6-hydroxyis utilized as a key component in the manufacturing of pharmaceuticals. Its biochemical properties contribute to the development of drugs that can address specific health conditions.
Used as a Biochemical Reagent:
In laboratories and research settings, Benzoic acid, 2-amino-6-hydroxy- serves as a biochemical reagent, facilitating various chemical reactions and analyses due to its reactivity and solubility.
Used in Food and Beverage Preservation:
Leveraging its natural antibacterial and antifungal properties, Benzoic acid, 2-amino-6-hydroxyis employed as a preservative in the food and beverage industry to extend the shelf life of products and maintain their quality.
Used in the Synthesis of Organic Compounds:
As an intermediate, Benzoic acid, 2-amino-6-hydroxy- plays a crucial role in the synthesis of other organic compounds, contributing to the creation of a wide range of chemical products.
Used in Dye and Pigment Production:
Benzoic acid, 2-amino-6-hydroxyalso serves as a precursor in the production of dyes and pigments, highlighting its importance in the coloration and appearance of various materials and products.
Check Digit Verification of cas no
The CAS Registry Mumber 567-62-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,6 and 7 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 567-62:
(5*5)+(4*6)+(3*7)+(2*6)+(1*2)=84
84 % 10 = 4
So 567-62-4 is a valid CAS Registry Number.
567-62-4Relevant articles and documents
Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infections
Hinsberger, Stefan,De Jong, Johannes C.,Groh, Matthias,Haupenthal, J?rg,Hartmann, Rolf W.
, p. 343 - 351 (2014/03/21)
Targeting PqsD is a promising novel approach to disrupt bacterial cell-to-cell-communication in Pseudomonas aeruginosa. In search of selective PqsD inhibitors, two series of benzamidobenzoic acids - one published as RNAP inhibitors and the other as PqsD inhibitors - were investigated for inhibitory activity toward the respective other enzyme. Additionally, novel derivatives were synthesized and biologically evaluated. By this means, the structural features needed for benzamidobenzoic acids to be potent and, most notably, selective PqsD inhibitors were identified. The most interesting compound of this study was the 3-Cl substituted compound 5 which strongly inhibits PqsD (IC 50 6.2 μM) while exhibiting no inhibition of RNAP.
